adjunctive mao-b or comt inhibitors to optimize levodopa treatment in pd
Published 2 years ago • 287 plays • Length 2:00Download video MP4
Download video MP3
Similar videos
-
1:18
adjunctive mao-b or comt inhibitors for parkinson's disease
-
2:29
comt inhibitors for parkinson's disease
-
1:52
mao inhibitors for parkinson's disease
-
1:18
comt inhibitors for motor fluctuations in parkinson’s disease
-
1:06
comt inhibitors for parkinson’s disease: clinical updates
-
1:19
maob inhibitors for the treatment of parkinson’s
-
1:07
comt inhibitors for the treatment of parkinson’s
-
17:53
parkinson's disease drugs iii: dopamine agonists & comt/mao-b inhibitors
-
6:49
comt & comt inhibitors
-
42:34
parkinson's medications - part 2: dopamine agonists, mao-b inhibitors, and more
-
41:11
parkinson's disease medications overview - uf pd symposium 2022
-
2:35
levodopa dose adjustment versus adjunctive therapy in parkinson’s disease
-
4:01
neurology news network: week of january 15, 2022.
-
20:31
recognition and management of wearing off utilisation of comt inhibitors – oliver rascol
-
5:04
managing parkinson’s “off times” with mao-b inhibitors | pd medications, purposes, and mechanisms #2
-
1:00:19
maximizing parkinson's disease medications: how to get the most out of your treatment plan
-
35:02
moving toward optimal management of advanced parkinson’s disease
-
30:22
repositioning comt inhibitors and response duration in levodopa optimisation – round table
-
22:12
parkinson's disease